HAE
C1-INH replacement and specific inhibition of plasma kallikrein with ecallantide have been successful in the treatment of hereditary angioedema (HAE), a more common related disorder.
<span class="gene" id="23406939-2-0-6">C1-INH</span> replacement and specific inhibition of plasma kallikrein with ecallantide have been successful in the treatment of <span class="disease" id="23406939-2-122-143">hereditary angioedema</span> (<span class="disease" id="23406939-2-145-148">HAE</span>), a more common related disorder.